Overall read
Proceed with caution
Selected: LGD-4033 / Ligandrol, Enclomiphene, Ostarine (MK-2866), RAD-140 / Testolone. This is a triage layer, not a dosing or safety clearance.
The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.
Interaction intelligence
Select up to eight compounds and review known synergies, redundancies, cautions, and unknowns. Unknown is shown honestly instead of guessed.
Overall read
Selected: LGD-4033 / Ligandrol, Enclomiphene, Ostarine (MK-2866), RAD-140 / Testolone. This is a triage layer, not a dosing or safety clearance.
No interaction data — community use appears common but no published data exists for this combination.
Confidence: unknown · Evidence: No pair-specific source/rationale in the current interaction dataset.
Source/rationale: Fallback: unknown pair
Ligandrol and Ostarine both target androgen receptors. Stacking increases class burden without necessarily improving risk-adjusted outcomes.
Confidence: mechanistic · Evidence: Mechanistic class overlap; community use is not clinical safety evidence.
Caution: Suppression, lipids, liver enzymes, blood pressure, mood, and WADA status are key warnings.
Source/rationale: SARM class-overlap pharmacology
No interaction data — community use appears common but no published data exists for this combination.
Confidence: unknown · Evidence: No pair-specific source/rationale in the current interaction dataset.
Source/rationale: Fallback: unknown pair
No interaction data — community use appears common but no published data exists for this combination.
Confidence: unknown · Evidence: No pair-specific source/rationale in the current interaction dataset.
Source/rationale: Fallback: unknown pair
No interaction data — community use appears common but no published data exists for this combination.
Confidence: unknown · Evidence: No pair-specific source/rationale in the current interaction dataset.
Source/rationale: Fallback: unknown pair
RAD-140 and Ostarine are both SARMs with overlapping androgen-receptor activity. Combining can compound suppression, lipid changes, liver-enzyme context, and androgenic adverse effects.
Confidence: mechanistic · Evidence: Class-overlap pharmacology and community reports; no safety endorsement.
Caution: Avoid framing as safe. Labs and clinician oversight matter; sport eligibility and WADA concerns apply.
Source/rationale: SARM androgen-receptor class overlap